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The ability of hormones such as insulin, leptin, and cholecystokinin to alter food intake is influenced by intri-
cate interactions between homeostatic and non-homeostatic factors. Consequently, when administered
exogenously, the likelihood of these hormones influencing food intake is probabilistic, leading to difficulties
replicating previously reported outcomes both within and between labs.The act of eating is the behavioral result of
diverse neural interactions, ultimately
activating motor neurons in the brainstem
to control salivating, biting, chewing, and
swallowing required for consuming the
food. These behaviors are dependent on
both homeostatic (based on energy
needs or deficits of specific nutrients)
and non-homeostatic factors (environ-
mental constraints, hedonics, palatability,
opportunity, cognition/learning/experi-
ence, and the social situation). Terms
including appetite, hunger, wanting and
liking, satiety, and satiation are commonly
used to summarize the net effect of these
neural processes, but they often belie the
complexity of the interacting neural cir-
cuitry and activity. Scientists examining
these processes are generally limited to
assessing the amount of food actually
consumed by experimental subjects in a
specified amount of time, in a controlled
environment and under experimental con-
ditions. When these conditions include
administration of compounds (hormones,
neurotransmitters, nutrients, etc.) hypoth-
esized to influence food intake, outcomes
have often been contradictory and diffi-
cult to interpret (Woods and Langhans,
2012). This short perspective highlights
some of the problems and misinterpreta-
tions that have arisen in assessing the
neurobiology of food intake.
Development of the Homeostatic
Model of Food Intake
Several findings in the 1960s and 1970s
led our lab to conclude that insulin, acting
within the brain, should cause animals to
eat less food and lose body weight over
time. These findings included the demon-348 Cell Metabolism 22, September 1, 2015 ªstration that both basal and glucose-
stimulated insulin secretion, and conse-
quently insulin levels in the blood, are
directly correlated with body weight/fat;
that contrary to then-prevailing under-
standing, both insulin and insulin recep-
tors are found in the brain; and that
increased plasma insulin results in insulin
crossing the blood-brain barrier, elevating
insulin levels in the brain and cerebrospi-
nal fluid (CSF). To assess our hypothesis,
we initially infused low amounts of insulin
into the CSF of baboons (via the lateral
ventricles) and observed a dose-depen-
dent reduction of food intake and body
weight (Woods et al., 1979), and over the
subsequent years we extended the basic
observation to rats, mice, and marmots;
many other investigators replicated the
hypophagic action of insulin in the brain
of many species and extended the finding
to humans. When insulin is administered
directly into the brain and reduces food
intake, it does so without causing malaise
or fatigue. Further, reducing insulin recep-
tor activity in the brain by genetic or phar-
macological means causes animals to eat
more and gain weight. Thus, insulin came
to be considered by some as an adiposity
signal to the brain: when its levels in-
crease it signifies an increase of body
fat, and when they decrease it indicates
a loss of body fat and changes of food
intake are recruited to return body fat
to normal (Begg and Woods, 2013).
When leptin was discovered, it was found
to share many of the same properties
as insulin: it is secreted in direct propor-
tion to body fat, and it penetrates the
blood-brain barrier and acts on leptin
receptors in the hypothalamus and2015 Elsevier Inc.other brain areas important in the control
of metabolism. Further, experimentally
induced increases of leptin locally in the
brain elicit decreased food intake and
body weight, and decreases of leptin
activity in the brain result in overeating
and weight gain. Such observations
were consistent with a homeostatic view
of body weight. When an individual diets
(or is food-restricted), body weight and
consequently plasma insulin and leptin
decrease, the combined leptin and insulin
signals in the brain also decrease, and
the individual eats more food and regains
lost weight. Analogously, eating more
food than is required to maintain body
weight results in weight gain, elevated
plasma and brain insulin and leptin levels,
and a tendency to eat less and lose
weight. Our lab espoused this homeostat-
ic model in reviews that have become
highly influential and often cited (Schwartz
et al., 2000; Woods et al., 1998), but in
retrospect the model has proven to be
overly simplistic and misleading, since
it implies that hormonal influences over
food intake are essentially hard-wired
reflexes.
Replication Problems in the Study
of Food Intake
As compelling as the homeostatic model
is, many data fail to support it. Within
our own lab, while many grad students
and fellows administer insulin into the
brain of rats or mice and observe reduc-
tions of food intake, others—with animals
often taken from the same shipment
and housed in the same room and
using seemingly identical techniques and
administered insulin—observe no change
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Figure 1. Intraventricular Leptin Reduces
Food Intake in One Environment and Not in
Another
Percent of 4 hr food intake following saline (open
bars, 100%) or i3vt leptin (3.5 mg; solid bars) in
three published experiments conducted in Seattle
(S1–S3) and three unpublished experiments con-
ducted in Cincinnati (C7, C15, C22) by the same
experimenter and with all other parameters the
same. Although only one dose and one time point
are depicted, the outcomes were comparable
across many doses and times; i.e., i3vt leptin
did not reduce food intake in any of the first 28
experiments conducted in Cincinnati. * denotes
p < 0.05 from saline. Details of the specific ex-
periments depicted are in Woods and Langhans
(2012).
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the insulin. It is important to note that
whether insulin ‘‘works’’ or doesn’t work,
there is no change of within-group vari-
ance. As a rule, all (or most) animals in a
group respond or not; i.e., it is not as if a
few respond such that including more
subjects would result in a significant ef-
fect. Rather, animals administered insulin
into the brain respond with comparable
variance as controls.
This situation is obviously frustrating for
trainees and has resulted in a lot of tears,
with the occasional trainee leaving the
lab with a sense of failure. But this phe-
nomenon is not unique to our lab;
numerous colleagues from around the
world have informed us over the years
that, try as they might, they have not
been able to get centrally administered in-
sulin to reduce food intake, or else they
sometimes observe that effect and other
times not, rendering it too unreliable for
their purposes. Although experiments
failing to replicate an effect rarely get pub-
lished, there are occasional exceptions.
For example, in one report a Herculean
effort was made to document central in-
sulin-induced hypophagia, but failed,
stating, ‘‘Although we varied rat strain,
stereotactic coordinates, formulations of
insulin and vehicle, dose, volume, and
time of injection, the anorectic effect of in-
tracerebroventricular insulin could not be
replicated’’ (p. R43) (Jessen et al., 2010).In sum, dozens of reports have docu-
mented that insulin, when administered
directly into the brain—and especially
into the region of the mediobasal hypo-
thalamus—reduces food intake, and, if
continued chronically, body weight as
well. This effect on food intake has been
widely studied, in several species, under
different experimental conditions, and
using a wide range of doses. The hypo-
phagic response to central insulin admin-
istration is more robust in males than in
females, including in humans. It reduces
food intake in animals fed relatively low-
fat chow diets, but not in high-fat dietary
obese animals or genetically obese ani-
mals, indicating that obesity results in
central as well as peripheral insulin resis-
tance. Further, considerable progress
has been made in determining the under-
lying molecular mechanisms and neural
circuitry of the response (Begg and
Woods, 2013). In spite of this knowledge,
when an experiment utilizing insulin
administration into the brain and assess-
ing food intake is planned, it cannot be
predetermined whether or not the ex-
periment will ‘‘work.’’ Rather, some un-
known factor(s) seems to dictate whether
or not insulin, when administered into
the brain, will reduce food intake or have
no effect relative to a control administra-
tion. Over the years, our lab, and others
with whom we have spoken, have sys-
tematically ruled out obvious potential
confounds, including using an ineffective
formulation or batch of insulin, the wrong
dose, the wrong vehicle, adverse lab con-
ditions (cleanliness, temperature, humidi-
ty, noise, etc.), animals that have been
poorly handled or generally stressed,
sickness or infection in the colony, disrup-
tion by animal care staff, or experimenter
bias. In short, a pervasive and as yet
unknown factor(s) simply negates the
ability of centrally administered insulin to
reduce food intake.
Failures to Replicate Are More
Generalized
Although not as notorious as insulin, leptin
can also be unreliable at reducing food
intake when administered into the brain.
Soon after leptin was discovered, it was
found to reduce food intake. Randy
Seeley, who was then in our group at
the University of Washington, published
several reports documenting that intra-
ventricular leptin reduces food intake inCell Metabolism 22, Srats (see Figure 1, left side). Our lab then
moved from Seattle to the University of
Cincinnati, including Seeley as well as
the technician who had conducted the
experiments with leptin in Seattle. After
setting up the new lab, Seeley and the
technician tried, but failed, to get rats to
decrease their food intake when leptin
was administered into the brain at the
same dose and using the same para-
meters as in Seattle. In fact, no set of
parameters of leptin administration was
efficacious at reducing food intake for
the first year and a half, as determined in
more than 25 separate ‘‘failed’’ experi-
ments (see Figure 1, right side, for repre-
sentative data from 3 experiments). At
some point, leptin mysteriously started
working again and has reduced food
intake relatively reliably (around 90% of
the time) since. Other investigators have
told us that they have around the same
success rate with intraventricular leptin,
and, importantly and like the case with
insulin, the ‘‘failures’’ afflict the entire
experimental group rather than a few ani-
mals within a larger group. As is also the
case with insulin, failures to observe the
hypophagia do not get published.
It is important to consider whether such
failures to replicate an effect of a com-
pound on food intake, one that was
obtained in prior experiments, is publish-
able. When a finding is novel (e.g., when
we found that insulin reduces food intake
in baboons) and has not yet been widely
replicated, there is a window of time
when negative findings can be published.
In modern times, this period of vulnera-
bility to alternative explanations can last
a year or two, but at some point dogma
sets in and the scientific community ac-
cepts that a certain compound actually
does have its stated effect. From then
on, failures to observe the phenomenon
become attributed to unknown factors
and the experiment is rerun until the
basic phenomenon occurs—and only
the positive results are likely to appear
in the literature. Negative (i.e., contrary)
results are no longer newsworthy.
Insulin and leptin can be considered as
adiposity signals that help maintain long-
term body weight. One might therefore
hypothesize that other classes of com-
pounds influencing food intake are not
subject to the same inconsistencies, but
this is not the case. Similar problems
have occurred with satiation signals,eptember 1, 2015 ª2015 Elsevier Inc. 349
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tinal tract during meals that signal the
nervous system to create a perception of
fullness or satiation. The first satiation
signal described, cholecystokinin (CCK),
dose-dependently and acutely reduces
meal size, with hundreds of reports docu-
menting this effect. Nonetheless, prior to
when dogma had been firmly established,
there were several published failures
to observe CCK-induced satiation includ-
ing one report where CCK ‘‘worked’’ in
some experiments but not in others.
CCK-induced satiation is widely accepted
as gospel today, although as discussed
below there are caveats.
Since CCK, myriad gut peptides and
other compounds have been suggested
to be satiation factors. Rather than
belabor the point, we cite two further ex-
amples. In 2002, Batterham, Bloom, and
colleagues, in a well-controlled series of
experiments using multiple approaches,
published that peptide YY (PYY), a
hormone secreted from the distal small
intestine, reduces food intake in mice
and in humans (Batterham et al., 2002).
Because of the potential clinical impor-
tance of the observation, numerous
groups began experimenting with PYY
and food intake, not always with success,
and in 2004 a publication from 42 authors
representing 15 different labs claimed
that PYY had no effect whatsoever on
food intake (Tscho¨p et al., 2004). How-
ever, to date, in excess of 500 publica-
tions have investigated PYY and food
intake, with most reporting that PYY re-
duces eating behavior.
Zhang et al. (2005) reported that obe-
statin, a peptide from the same gene
that produces ghrelin, reduces food
intake, and the basic findings were soon
replicated by a group from Johnson &
Johnson Pharmaceutical Research and
Development (Lagaud et al., 2007). At
the same time, another cadre of investiga-
tors from several labs could not replicate
the basic finding, stating, ‘‘In the present
study, we failed to observe any effect of
obestatin on food intake, BW, body
composition, energy expenditure, loco-
motor activity, respiratory quotient, or
hypothalamic neuropeptides involved in
energy-balance regulation. Therefore,
the results presented here do not support
a role of the obestatin/GPR-39 system in
the regulation of energy balance’’ (p. 21)
(Nogueiras et al., 2007). One important350 Cell Metabolism 22, September 1, 2015 ªconsequence of this was that Johnson &
Johnson retracted their published article,
stating, ‘‘The authors have found inaccur-
acies with the experimental data, specif-
ically that recent feeding data obtained
in the laboratory (in rats and mice) could
not be reproduced using the same ex-
perimental protocol or even a more so-
phisticated system (BioDaq system). The
long-term effects of obestatin on change
in body weight (mice) could not be repro-
duced as well. The authors would like to
apologize for this error’’ (p. 619) (Lagaud,
2009). Since then, there have been both
reported failures and successes in repli-
cating the original observation of obesta-
tin-induced hypophagia.
Summaries of failures to replicate the
effectsofothercompoundson food intake,
including some peptides that are orexi-
genic, can be found in Woods and Lan-
ghans (2012). The important point is that
administering a compound and assessing
food intake is an iffy undertaking. Many
factors can interfere, including some that
are unknown. Thus, a failure to replicate
your own previous results, or the findings
of others, should not be taken as a sign
that something was done wrong. In partic-
ular, failing to replicate one’s own findings
and consequently retracting a publication
in this area of research as was done for
obestatin, sets a high bar, and one that
few could meet. Science should be based
on solid data rather than on influential in-
vestigators swaying opinion.
Factors That May Account for
Replication Issues
Anytime the nervous system is involved in
the response to an input, the likelihood
that the response will be manifest is not
certain. For many responses, the range
of probabilities of its occurrence can be
quite high. At one end of a continuum is
the passage of information across the
neuromuscular junction. A motor nerve is
activated and releases its neurotrans-
mitter onto receptors in the junction, and
the muscle cell contracts. This is as near
to a one-to-one cause and effect as
occurs. Moving back into the central ner-
vous system, however, the motor nerve it-
self is innervated by multiple inputs from
different circuits and neuronal types.
Whether or not an action potential is
elicited along the motor neuron axon to
its junction with a skeletal muscle is
consequently probabilistic, depending2015 Elsevier Inc.upon a complex calculus of the excitatory
and inhibitory inputs it is receiving. When
a circuit influencing a behavior includes
only one or a very few synapses, such
as the pain reflex, the probability is high
that a painful stimulus will elicit the appro-
priate response. As the number of inter-
vening synapses between an input such
as insulin and a specific response such
as eating less increases, the probability
that the input will elicit a specific response
is reduced. This may well be the case for
hormones influencing food intake. Hor-
mones such as CCK—influencing circuits
in the hindbrain that are directly adjacent
to the motor units controlling eating—
have a relatively high, albeit not one
hundred percent, likelihood of reducing
meal size. In contrast, hormones such as
insulin—which stimulates neurons in the
mediobasal hypothalamus—elicit neural
signals that must be filtered through
many circuits before influencing food
intake. Consistent with this notion, the
proportion of time that CCK is found to
reduce food intake is much higher than
that for insulin. Leptin is intermediate be-
tween CCK and insulin, perhaps due to
the numerous other circuits activated by
central insulin involving glucose homeo-
stasis, cognition, and others. If all of the
data ever obtained in such experiments,
both positive and negative, were pub-
lished and available for meta-analysis,
there would likely be a gradient of proba-
bilities that a compound will influence
food intake that parallels the number of
intervening circuits.
Very few instances of eating are simple
homeostatic reflexes initiated by a deficit
of stored or available energy. Such re-
flexes do exist, for example when energy
to the brain is acutely reduced (as occurs
with sudden hypoglycemia induced by
systemic insulin administration) or when
brain cells are prevented from deriving
energy from available glucose (as occurs
when 2-deoxyglucose is acutely adminis-
tered). These are states of emergency that
can be evoked in laboratory experiments
but that do not occur in normal eating sit-
uations. Chronic food deprivation results
in loss of stored energy, but immediately
available circulating energy nonetheless
remains above the levels achieved by
insulin or 2-deoxyglucose (Woods and
Begg, in press).
Another potentially mitigating factor
relates to learned responses. Ingestive
Cell Metabolism
Crosstalkbehaviors can be markedly influenced by
factors that become associated with the
ingested food; one classic example of
this occurs with the phenomenon of
conditioned taste aversions, whereby
negative consequences such as visceral
illness that are associated with ingesting
a specific food or flavor results in future
avoidance of that food or flavor. The abil-
ity of a hormone to reduce food intake can
also be changed by experience. When
CCK is repeatedly administered in an
environment with stable and predictable
cues present, its ability to reduce food
intake in that environment is lessened
over trials; yet, CCK continues to reduce
food intake normally in other environ-
ments in the same animals (Goodison
and Siegel, 1995). Thus, the presence or
absence of some subtle environmental
stimulus might prevent an animal from
responding normally to CCK, or to any
other compound that influences food
intake, due to past experience. These ex-
amples demonstrate the complex interac-
tions that occur between endogenous
or exogenous cues and the effects of
experimental interventions on a complex
behavior. The overall point is that many
behaviors are influenced by such a broad
array of inputs that outcomes should be
anticipated to vary among trials or exper-
iments. In an important and revealing
report, large cohorts of six different ge-
netic strains of mice from the Jackson
Laboratories were shipped to three
different labs around North America and
then analyzed in each lab on a battery of
ostensibly identical behavioral tests. The
correspondence of performance on the
tests among the three sites was very lowwithin and among strains, highlighting
the inherent variability of behavioral out-
comes even when every effort is made
to ensure that experimental conditions
are comparable (Crabbe et al., 1999).
Food intake is a motivated behavior,
regulated by intricate interactions among
homeostatic and non-homeostatic as
well as exogenous and endogenous
factors. It is highly influenced by experi-
ence and learning (Ramsay and Woods,
2014). Because of all of these factors,
administered compounds purported to
influence food intake do so in a probabi-
listicmanner, which can lead to difficulties
replicating previously reported outcomes.REFERENCES
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